Average Co-Inventor Count = 8.17
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (8 from 169 patents)
2. Agouron Pharmaceuticals, Inc. (5 from 174 patents)
3. Cancer Research Campaign Technology Limited (2 from 61 patents)
4. Pfizer Corporation (1 from 4,455 patents)
14 patents:
1. 12129237 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
2. 11325890 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
3. 10919865 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
4. 10266500 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
5. 10040770 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
6. 9701643 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
7. 9139534 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
8. 8299056 - Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
9. 7884117 - Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
10. 7429578 - Tricyclic inhibitors of poly(ADP-ribose) polymerases
11. 6977298 - Tricyclic inhibitors of poly(ADP-ribose) polymerases
12. 6906198 - Antipicornaviral compounds, their preparation and use
13. 6548494 - Tricyclic inhibitors of poly(ADP-ribose) polymerases
14. 6495541 - Tricyclic inhibitors of poly(ADP-ribose) polymerases